Technology is extending the range of CRO superheroes and what they can offer clients.
The life sciences industry is undergoing radical shifts, and the contract research organizations (CROs) that take advantage of the new landscape stand to play a crucially important role. In search of greater efficiency, as the cost of getting drugs to market continues to rise, upwards of $1.3 billion last year, life sciences companies are increasingly turning to CROs for clinical trials.